Associated Papers
Integrating Clinical Cancer and PTM Proteomics Data Identifies a Mechanism of ACK1 Kinase Activation.
Balasooriya ER et al.
Molecular Cancer Research : Mcr, 2024
Identification and Characterization of Tyrosine Kinase Nonreceptor 2 Mutations in Leukemia through Integration of Kinase Inhibitor Screening and Genomic Analysis.
Maxson JE et al.
Cancer Research, 2016
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer.
Kopetz S et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 2015
26460303 (PubMed )
Supplement: supp_33.34.4032_DS_2015.632497.pdf
ACK1/TNK2 tyrosine kinase: molecular signaling and evolving role in cancers.
Mahajan K et al.
Oncogene, 2015
Conjunctival melanomas harbor BRAF and NRAS mutations and copy number changes similar to cutaneous and mucosal melanomas.
Griewank KG et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2013
23633454 (PubMed )
Supplement: 10780432ccr130163-sup-tab1-3.pdf
Shepherding AKT and androgen receptor by Ack1 tyrosine kinase.
Mahajan K et al.
Journal of Cellular Physiology, 2010
Select a paper to view details